Transferrin-Modified Triptolide Liposome Targeting Enhances Anti-Hepatocellular Carcinoma Effects

Transferrin-Modified Triptolide Liposome Targeting Enhances Anti-Hepatocellular Carcinoma Effects

Triptolide (TP) is an epoxy diterpene lactone compound isolated and purified from the traditional Chinese medicinal plant <i>Tripterygium wilfordii</i> Hook. f., which has been shown to inhibit the proliferation of hepatocellular carcinoma. However, due to problems with solubility, bioav...

Full description

Bibliographic Details
Main Authors:	Xiaoli Zhao, Yifan Yang, Xuerong Su, Ying Xie, Yiyao Liang, Tong Zhou, Yangqian Wu, Liuqing Di
Format:	Article
Language:	English
Published:	MDPI AG 2023-10-01
Series:	Biomedicines
Subjects:	targeted therapy lipidosome transferrin anti-tumor hepatocellular carcinoma fluorescence imaging
Online Access:	https://www.mdpi.com/2227-9059/11/10/2869

Similar Items

Fe3+-binding transferrin nanovesicles encapsulating sorafenib induce ferroptosis in hepatocellular carcinoma
by: Youmei Xiao, et al.
Published: (2023-07-01)

A Novel Triptolide Nano-Liposome with Mitochondrial Targeting for Treatment of Hepatocellular Carcinoma
by: Zhou L, et al.
Published: (2024-12-01)

Anlotinib potentiates anti‐PD1 immunotherapy via transferrin receptor‐dependent CD8+ T‐cell infiltration in hepatocellular carcinoma
by: Fei Song, et al.
Published: (2024-08-01)

Evaluation of salivary transferrin in patients with oral squamous cell carcinoma
by: Fatemeh Tavakoli, et al.
Published: (2024-02-01)

Pathophysiological aspects of transferrin-A potential nano-based drug delivery signaling molecule in therapeutic target for varied diseases
by: Chang Li, et al.
Published: (2024-03-01)

Homotypic cell membrane-camouflaged biomimetic PLGA nanoparticle loading triptolide for the treatment of hepatocellular carcinoma
by: Zhe Li, et al.
Published: (2024-12-01)

Serum Soluble Transferrin Receptor and Transferrin Levels among Regular Blood Donors
by: Samuel K. Appiah, et al.
Published: (2022-09-01)

Productivity Analysis of the Botosani Karakul Sheep Depending on the Genetic Types of Serum Transferrin
by: Gheorghe Hrincă, et al.
Published: (2023-11-01)

Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer
by: Pranali Deshpande, et al.
Published: (2018-01-01)

Controversial Role of Transferrin in the Transport of Ruthenium Anticancer Drugs
by: Aviva Levina, et al.
Published: (2022-09-01)

Effect of transferrin glycation induced by high glucose on HK-2 cells in vitro
by: Yanqi Ma, et al.
Published: (2023-01-01)

An Improved Method for Quick Quantification of Unsaturated Transferrin
by: Ruirui Guo, et al.
Published: (2022-09-01)

Transferrin levels are associated with malnutrition markers in hemodialysis patients in KwaZulu-Natal, South Africa
by: Sherilene Benjamin, et al.
Published: (2024-12-01)

The Trypanosomal Transferrin Receptor of Trypanosoma Brucei—A Review
by: Christopher K. Kariuki, et al.
Published: (2019-10-01)

Transferrin polymorphism of arabian horses in turkey
by: Metehan Uzun, et al.

Boosting physical performance in SD rats through brain-targeted delivery of caffeine-loaded transferrin liposomes
by: Hezhang Yun, et al.
Published: (2024-07-01)

Hyaluronic acid-modified liposomes Potentiated in-vivo anti-hepatocellular carcinoma of icaritin
by: Xiaoduan Sun, et al.
Published: (2024-07-01)

Sorafenib and triptolide loaded cancer cell-platelet hybrid membrane-camouflaged liquid crystalline lipid nanoparticles for the treatment of hepatocellular carcinoma
by: Zhe Li, et al.
Published: (2021-11-01)

Preparation of transferrin-modified IR820-loaded liposomes and its effect on photodynamic therapy of breast cancer
by: Zhang Di, et al.
Published: (2024-11-01)

Targeted Drug Delivery Strategies for the Treatment of Hepatocellular Carcinoma
by: Yonghui Liu, et al.
Published: (2024-09-01)

Dual-targeting liposomal delivery of sorafenib and docetaxel for enhanced synergistic therapy in advanced hepatocellular carcinoma
by: Yawen Yao, et al.
Published: (2024-12-01)

Influence of serum transferrin concentration on diagnostic criteria for iron deficiency in chronic heart failure
by: Fraser J. Graham, et al.
Published: (2023-10-01)

Advances in transdermal siRNAs delivery: A review of current research progress
by: Albert Sufianov, et al.
Published: (2023-09-01)

Selective Hydrolysis of Transferrin Promoted by Zr-Substituted Polyoxometalates
by: Laura S. Van Rompuy, et al.
Published: (2020-07-01)

Neoadjuvant therapy for hepatocellular carcinoma—priming precision innovations to transform HCC treatment
by: Kristin E. Goodsell, et al.
Published: (2025-03-01)

Transferrin coupled azanthraquinone enhances the killing effect on trypanosomes. The role of lysosomal mannosidase
by: Nok A.J., et al.
Published: (2002-12-01)

Evaluation of binding mechanism of dietary phytochemical, capsaicin, with human transferrin: targeting neurodegenerative diseases therapeutics
by: Mohammed Alrouji, et al.
Published: (2024-03-01)

Correlation between serum transferrin receptor and percentage of parasitemia in malaria. A preliminary report
by: Wiwanitkit V., et al.
Published: (2007-06-01)

Antiproliferative and Apoptosis Triggering Potential of Paclitaxel-Based Targeted-Lipid Nanoparticles with Enhanced Cellular Internalization by Transferrin Receptors—a Study in Leukemia Cells
by: Yang Dai, et al.
Published: (2018-09-01)

Super-enhancers in hepatocellular carcinoma: regulatory mechanism and therapeutic targets
by: Xuejin Lu, et al.
Published: (2025-01-01)

Clinical significance of RNA methylation in hepatocellular carcinoma
by: Qiongling Bao, et al.
Published: (2024-04-01)

O-GlcNAcylation regulates the stability of transferrin receptor (TFRC) to control the ferroptosis in hepatocellular carcinoma cells
by: Xunyu Zhou, et al.
Published: (2024-07-01)

Clinical outcomes of rare hepatocellular carcinoma variants compared to pure hepatocellular carcinoma
by: Zakka K, et al.
Published: (2019-07-01)

Transferrin receptor 1-mediated iron uptake regulates bone mass in mice via osteoclast mitochondria and cytoskeleton
by: Bhaba K Das, et al.
Published: (2022-06-01)

Recent advances in systemic therapy for hepatocellular carcinoma
by: Huajun Zhang, et al.
Published: (2022-01-01)

Transferrin Receptor-Targeted Nanocarriers: Overcoming Barriers to Treat Glioblastoma
by: Maria João Ramalho, et al.
Published: (2022-01-01)

BLOOD PROTEIN TRANSFERRIN POLYMOROPHISM IN BLACK BENGAL GOAT
by: Rajesh Paul, et al.
Published: (2017-12-01)

ASSOCIATION OF TRANSFERRIN POLYMORPHISM WITH REPRODUCTVE TRAITS OF GIR CATTLE
by: R. Guha, et al.
Published: (2012-01-01)

Transferrin receptor-1 and VEGF are prognostic factors for osteosarcoma
by: Hongzeng Wu, et al.
Published: (2019-09-01)

Proteomic Characterization of Liver Cancer Cells Treated with Clinical Targeted Drugs for Hepatocellular Carcinoma
by: Hezhou Long, et al.
Published: (2025-01-01)